BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18311852)

  • 1. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
    Rousson V; Seifert B
    Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes.
    Durkalski VL; Berger VW
    Biom J; 2009 Feb; 51(1):185-92. PubMed ID: 19197960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
    Laster LL; Johnson MF; Kotler ML
    Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A score test for establishing non-inferiority with respect to short-term survival in two-sample comparisons with identical proportions of long-term survivors.
    Broët P; Tubert-Bitter P; De Rycke Y; Moreau T
    Stat Med; 2003 Mar; 22(6):931-40. PubMed ID: 12627410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-inferiority trials in surgical oncology.
    Fueglistaler P; Adamina M; Guller U
    Ann Surg Oncol; 2007 May; 14(5):1532-9. PubMed ID: 17294075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined superiority and non-inferiority approach to multiple endpoints in clinical trials.
    Bloch DA; Lai TL; Su Z; Tubert-Bitter P
    Stat Med; 2007 Mar; 26(6):1193-207. PubMed ID: 16791905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?].
    Marubini E; Rebora P; Reina G
    Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
    Friede T; Mitchell C; Müller-Velten G
    Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic equivalence: fallacies and falsification.
    Garrett AD
    Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.